Mark Dittmar

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Dendritic Cells

Top Venues

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Mark Dittmar, Kanupriya Whig, Jesse Miller, Brinda Kamalia, Suganthi Suppiah, Ludmila Perelygina, Kathleen E Sullivan, David C. Schultz, Sara Cherry
Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus. PNAS nexus 2 (9) (2023)
David C. Schultz, Robert M Johnson, Kasirajan Ayyanathan, Jesse Miller, Kanupriya Whig, Brinda Kamalia, Mark Dittmar, Stuart Weston, Holly L Hammond, Carly Dillen, Jeremy Ardanuy, Louis Taylor, Jae Seung Lee, Minghua Li, Emily Lee, Clarissa Shoffler, Christopher Petucci, Samuel Constant, Marc Ferrer, Christoph A Thaiss, Matthew B Friemann, Sara Cherry
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature 604 (7904) (2022)
Christine Vazquez, Sydnie E Swanson, Seble G Negatu, Mark Dittmar, Jesse Miller, Holly R Ramage, Sara Cherry, Kellie Ann Jurado
SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PloS one 16 (6) (2021)
Minghua Li, Max B Ferretti, Baoling Ying, Hélène C Descamps, Emily M Lee, Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Brinda Kamalia, Lenka Dohnalová, Giulia Uhr, Hoda Zarkoob, Yu-Chi Chen, Holly Ramage, Marc Ferrer, Kristen Lynch, David C. Schultz, Christoph A. Thaiss, Michael S. Diamond, Sara Cherry
Pharmacological activation of STING blocks SARS-CoV-2 infection. Science immunology 6 (59) (2021)